 Indian pharma industry: The road ahead…
There has been a dramatic growth in the pharmaceutical market in India, during the last two decades, more so in the last few years. Earlier, Indian pharma companies were quite successful in both the domestic and overseas markets with their expertise in reverse engineering. However, as things stand today, the industry has realised that its ability to discover & develop new drugs depends on the competitive forces in the market and the availability of talent pool. In fact, some leading Indian companies have already adapted their business as per global demands and are surging ahead through world-class R&D facilities, global alliances, licensing and contract manufacturing, among others.
The next few years will be crucial for the industry as more and more changes come in, especially as India moves towards a patent regime as required by TRIPs. ‘Modern Pharmaceuticals’, on the occasion of its First Anniversary, invited doyens of the industry to express their views and vision to face these challenges. Excerpts…
- Dr Ajit Dangi, director general, OPPI
- D G Shah, chairman, IGPA; secretary general, IPA & CEO, Vision Consulting Group
- Dr Gopakumar G Nair, IPR consultant and advisor
- Dr M D Nair, consultant
|
